The epilepsy medication valproate is responsible for "severe malformations" in 2,150 to 4,100 children in France since the drug was first marketed in the country in 1967, according to a preliminary study by French health authorities.
Women who took the drug during pregnancy to treat epilepsy were four times more likely to give birth to babies with congenital malformations, said the report, jointly issued by the French National Agency for the Safety of Medicines (ANSM) and the national health insurance administration.
"The study confirms the highly teratogenic" -- that is, capable of causing birth defects --- "nature of valproate," Mahmoud Zureik, scientific director of ANSM and co-author of the report, told AFP ahead of its release.
GMT 13:29 2018 Friday ,14 December
Turkey targets military over alleged Gulen linksGMT 09:32 2018 Wednesday ,12 December
Huawei CFO gets bail; China detains ex-Canadian diplomatGMT 09:24 2018 Wednesday ,12 December
LuLu supports KFUPM Rectors Cup marathonGMT 09:12 2018 Wednesday ,12 December
Ford trains 1,600 motorists in Mideast, Africa in 2018GMT 09:00 2018 Wednesday ,12 December
May tours Europe in desperate bid to save Brexit dealGMT 08:26 2018 Wednesday ,12 December
Australian government discusses moving Israel embassy to JerusalemGMT 10:32 2018 Tuesday ,11 December
Trump’s troubled White House in search of new chief of staffGMT 10:03 2018 Monday ,10 December
23 Palestinians arrested in West BankMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor